Reference
Kaushik V, et al. Real-life safety profile of biosimilar adalimumab in patients with inflammatory arthritic conditions. Annals of the Rheumatic Diseases 76 (Suppl. 2): 561 abstr. FRI0209, Jun 2017. Available from: URL: http://doi.org/10.1136/annrheumdis-2017-eular.2357 [abstract] - India
Rights and permissions
About this article
Cite this article
Adalimumab/methotrexate. Reactions Weekly 1697, 19 (2018). https://doi.org/10.1007/s40278-018-44575-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44575-0